# Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

> **NCT00235859** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 128 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** adalimumab
- **DRUG:** methotrexate

## Key facts

- **NCT ID:** NCT00235859
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2007-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235859, "Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00235859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*